Willis Towers Watson Public Limited Company (WTW)
NASDAQ$337.95+0.79 (0.23%)
Market Cap
$33.61B
Sector
Financial Services
Industry
Insurance—Brokers
Rank in Sector
634 of 637
Rank in Industry
13 of 13
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
WTW Insider Trading Activity
WTW Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $1,683,648 | 2 | 100 |
Related Transactions
| Gebauer Julie Jarecke | Pres.-Health, Wealth & Career | 0 | $0 | 2 | $1.68M | $-1.68M |
About Willis Towers Watson Public Limited Company
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments, Health, Wealth and Career; and Risk and Broking. The company offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services. It also provides advice, data, software, and products to address clients' total …
Insider Activity of Willis Towers Watson Public Limited Company
Over the last 12 months, insiders at Willis Towers Watson Public Limited Company have bought $0 and sold $1.68M worth of Willis Towers Watson Public Limited Company stock.
On average, over the past 5 years, insiders at Willis Towers Watson Public Limited Company have bought $0 and sold $17.66M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,100 shares for transaction amount of $496,303 was made by Burwell Michael J (Chief Financial Officer) on 2017‑11‑06.
List of Insider Buy and Sell Transactions, Willis Towers Watson Public Limited Company
| 2025-03-03 | Sale | Gebauer Julie Jarecke | Pres.-Health, Wealth & Career | 1,616 0.0016% | $338.74 | $547,405 | -1.89% | |
| 2025-02-28 | Sale | Gebauer Julie Jarecke | Pres.-Health, Wealth & Career | 3,384 0.0034% | $335.77 | $1.14M | -1.60% | |
| 2024-03-01 | Sale | Krasner Andrew Jay | Chief Financial Officer | 1,100 0.0011% | $272.13 | $299,346 | +7.03% | |
| 2024-02-20 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 5,000 0.0049% | $276.03 | $1.38M | +3.59% | |
| 2024-02-08 | Sale | Garrard Adam | Head of Risk & Broking | 5,400 0.0057% | $270.41 | $1.46M | +4.42% | |
| 2023-11-09 | Sale | Thomson-Hall Pamela | Head of International | 330 0.0003% | $238.87 | $78,828 | +12.11% | |
| 2023-07-03 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 2,000 0.0019% | $231.69 | $463,384 | +5.31% | |
| 2023-06-07 | Sale | Pullum Anne | Head of Europe | 5,000 0.0047% | $224.45 | $1.12M | +8.38% | |
| 2023-06-01 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 2,500 0.0023% | $218.35 | $545,868 | +10.14% | |
| 2023-05-01 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 2,500 0.0023% | $231.44 | $578,590 | +1.24% | |
| 2023-04-03 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 5,000 0.0047% | $232.38 | $1.16M | +0.52% | |
| 2023-04-03 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 2,500 0.0023% | $232.38 | $580,941 | +0.52% | |
| 2023-03-01 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 5,000 0.0047% | $233.41 | $1.17M | +0.48% | |
| 2023-03-01 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 2,500 0.0023% | $233.41 | $583,514 | +0.48% | |
| 2023-02-14 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 6,000 0.0057% | $246.70 | $1.48M | -3.33% | |
| 2023-02-14 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 3,000 0.0029% | $246.70 | $740,103 | -3.33% | |
| 2023-02-09 | Sale | Bodnar Anne Donovan | Chief Administrative Officer | 10,000 0.0099% | $253.94 | $2.54M | -2.31% | |
| 2023-02-09 | Sale | Bodnar Anne Donovan | Chief Administrative Officer | 5,000 0.005% | $253.94 | $1.27M | -2.31% | |
| 2022-11-21 | Sale | Gebauer Julie Jarecke | Head of Health, Wealth &Career | 10,000 0.0092% | $235.07 | $2.35M | -1.14% | |
| 2022-11-18 | Sale | WICKES GENE H | Head of Benefits Deliv & Admin | 16,224 0.0152% | $235.00 | $3.81M | +0.63% |
Total: 66
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Burwell Michael J | Chief Financial Officer | 3100 0.0031% | $1.05M | 1 | 0 | <0.0001% |
WTW Institutional Investors: Active Positions
| Increased Positions | 358 | +49.38% | 8M | +8.75% |
| Decreased Positions | 308 | -42.48% | 7M | -7.91% |
| New Positions | 109 | New | 1M | New |
| Sold Out Positions | 68 | Sold Out | 531,418 | Sold Out |
| Total Postitions | 775 | +6.9% | 95M | +0.84% |
WTW Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $3.86M | 11.43% | 11.43M | +12,802 | +0.11% | 2024-12-31 |
| Blackrock, Inc. | $3.33M | 9.86% | 9.86M | -10,366 | -0.1% | 2024-12-31 |
| Massachusetts Financial Services Co /Ma/ | $2.19M | 6.48% | 6.48M | -1M | -13.68% | 2024-12-31 |
| First Eagle Investment Management, Llc | $1.5M | 4.46% | 4.46M | -672,829 | -13.12% | 2024-12-31 |
| State Street Corp | $1.47M | 4.36% | 4.36M | +73,938 | +1.73% | 2024-12-31 |
| Fmr Llc | $1.24M | 3.68% | 3.68M | +1M | +52.41% | 2024-12-31 |
| Harris Associates L P | $1.19M | 3.52% | 3.52M | -57,915 | -1.62% | 2024-12-31 |
| Artisan Partners Limited Partnership | $1.18M | 3.5% | 3.5M | -3,689 | -0.1% | 2024-12-31 |
| T. Rowe Price Investment Management, Inc. | $940,185.00 | 2.79% | 2.79M | +1M | +77.52% | 2024-12-31 |
| Geode Capital Management, Llc | $888,704.00 | 2.64% | 2.64M | +6,413 | +0.24% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.